Diabetes mellitus: An opportunity for therapy with regenerative medicine?

Medicine & Life Sciences

• Regenerative Medicine 100%
• Diabetes Mellitus 72%
• Stem Cells 66%
• Insulin 44%
• Induced Pluripotent Stem Cells 44%
• Cell- and Tissue-Based Therapy 37%
• Teratoma 29%
• Mesenchymal Stem Cells 23%
• Stem Cell Research 17%
• In Vitro Techniques 17%
• Islets of Langerhans Transplantation 16%
• Glucose 16%
• Histocompatibility 16%
• Human Embryonic Stem Cells 15%
• Adult Stem Cells 15%
• Therapeutics 14%
• Graft Rejection 14%
• Efficiency 14%
• Embryonic Stem Cells 13%
• Insulin Secretion 12%
• Immunosuppression 11%
• Type 1 Diabetes Mellitus 11%
• Cues 11%
• Pancreas 11%
• Immunosuppressive Agents 10%
• Blood Glucose 10%
• Type 2 Diabetes Mellitus 9%
• Cell Line 7%
• Pharmaceutical Preparations 5%

Chemical Compounds

• Insulin Derivative 93%
• Glucose 44%
• Immunosuppressive Agent 40%
• Developmental 36%
• Curing 27%
• Disorder 25%
• Metabolic 24%
• Donor 20%
• Reaction Yield 12%